| Followers | 125 |
| Posts | 5425 |
| Boards Moderated | 0 |
| Alias Born | 06/09/2020 |
Monday, October 24, 2022 5:20:57 AM
Truth will out. So far all of this is true -- Merck has shown no interest.
Your DD is second to none
No interest huh?
That's why Merck got UCLA to throw out Bristol Meyers Squibb from the SPORE 1 project in 2019 and replace Opdivo (nivolumab) with Keytruda (pembrolizumab), which is now the combo trial. A combo trial where Merck is sponsoring Keytruda FOR FREE, which big pharma usually DON'T DO.
I love your due diligence. It gives me some of the most humoristic moments every week.
Oh ... that is the cue for you claiming, that ATL-DC is not DCvax-L. That Linda Liau has distanced herself from NWBO (which is why she will talk about DCVax-L 3 times the next month) and she is making her "own version".
Oh I'm giggling myself to death now
Recent NWBO News
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
